Tailoring Cll Therapy

Summary

Danielle Brander, MD, of the Duke University School of Medicine, Durham, NC, discusses how clinicians can In this video, Lydia Scarfò, MD, Vita-Salute San Raffaele University & IRCCS San Raffaele Scientific Institute, Milan, Italy, shares ... Here, Danielle Brander, MD, of the Duke University School of Medicine, Durham, NC, discusses Lydia Scarfo, MD, Vita-Salute San Raffaele University, Milan, Italy, talks about the combination of ibrutinib and venetoclax and ... On location at ASH 2024 in Orlando, MD Anderson Cancer Center fellow Dr. Vanthana Bharthi sits down with Dr. Mahesh ... Dr. Nicole Lamanna, Associate Clinical Professor of haematological malignancies at Columbia University Medical Centre ... Are you selecting the right Bruton tyrosine kinase (BTK) inhibitor for your patients with John Allan, MD, Weill Cornell Medicine, New York, NY, discusses the future of Davide Rossi, MD, PhD from University of Eastern Piedmont, Vercelli, Italy outlines the novel Watch the full course and our most up-to-date content here: linktr.ee/HealthTreeUniversity Create a free account to track ... Tara Lin, MD, University of Kansas Medical Center, Kansas City, KS, discusses the possibility of Tycel Phillips, MD, FASCO, City of Hope, Duarte, CA, comments on the expanding